Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IMPACTonIMT: Probucol and/or Cilostazol in CHD
NCT01291641Phase 4Completed
- Sponsor
- Seoul National University Hospital
- Start
- Mar 2011
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of probucol, cilostazol in coronary heart disease (CHD), hyperlipidemia, sponsored by Seoul National University Hospital. Started Mar 2011; status: completed.
02
Drugs
probucolcilostazol
03
Conditions
coronary heart disease (CHD)hyperlipidemia
Beyond the preview
Go deeper on NCT01291641.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01291641.